# | Title | Journal | Year | Citations |
---|
1 | Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer | Oncology Reports | 2015 | 621 |
2 | Cisplatin and platinum drugs at the molecular level. (Review) | Oncology Reports | 2003 | 543 |
3 | Non-coding RNAs as regulators in epigenetics | Oncology Reports | 2017 | 493 |
4 | Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo | Oncology Reports | 2017 | 352 |
5 | Cancer drug delivery in the nano era: An overview and perspectives | Oncology Reports | 2017 | 310 |
6 | WNT/PCP signaling pathway and human cancer (review) | Oncology Reports | 2005 | 291 |
7 | Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review) | Oncology Reports | 2005 | 271 |
8 | Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density | Oncology Reports | 2005 | 263 |
9 | Role of the tumor microenvironment in tumor progression and the clinical applications (Review) | Oncology Reports | 2016 | 254 |
10 | microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN | Oncology Reports | 2012 | 251 |
11 | Genetics, diagnosis and management of colorectal cancer (Review) | Oncology Reports | 2015 | 247 |
12 | Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: A clinical and in vitro investigation | Oncology Reports | 2014 | 245 |
13 | Expression profile of class I histone deacetylases in human cancer tissues | Oncology Reports | 2007 | 237 |
14 | Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). | Oncology Reports | 1998 | 215 |
15 | Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma | Oncology Reports | 2013 | 215 |
16 | Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines | Oncology Reports | 2012 | 214 |
17 | Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. | Oncology Reports | 2000 | 213 |
18 | MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers | Oncology Reports | 2006 | 212 |
19 | Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review) | Oncology Reports | 2004 | 205 |
20 | Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function | Oncology Reports | 2015 | 196 |
21 | Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer | Oncology Reports | 2014 | 193 |
22 | MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2 | Oncology Reports | 2010 | 191 |
23 | Patterns of MMP-2 and MMP-9 expression in human cancer cell lines | Oncology Reports | 2009 | 190 |
24 | Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization | Oncology Reports | 2017 | 189 |
25 | Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis | Oncology Reports | 2017 | 187 |
26 | Diverse roles of miR-29 in cancer (Review) | Oncology Reports | 2014 | 185 |
27 | The emerging landscape of circular RNA ciRS-7 in cancer (Review) | Oncology Reports | 2015 | 183 |
28 | Cisplatin and platinum drugs at the molecular level (Review) | Oncology Reports | 2003 | 178 |
29 | Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation | Oncology Reports | 2013 | 173 |
30 | Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer | Oncology Reports | 2018 | 169 |
31 | Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review) | Oncology Reports | 2002 | 164 |
32 | Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway | Oncology Reports | 2015 | 161 |
33 | Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer | Oncology Reports | 2006 | 161 |
34 | Activation of STAT3 is a marker of poor prognosis in human colorectal cancer | Oncology Reports | 2006 | 161 |
35 | Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2 | Oncology Reports | 2017 | 159 |
36 | Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. | Oncology Reports | 2000 | 157 |
37 | Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer | Oncology Reports | 2003 | 157 |
38 | miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells | Oncology Reports | 2013 | 155 |
39 | Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). | Oncology Reports | 1998 | 154 |
40 | Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer | Oncology Reports | 2014 | 152 |
41 | Comparative genomics on Fgf11 orthologs. | Oncology Reports | 2005 | 149 |
42 | Downregulated microRNA-200a promotes EMT and tumor growth through the Wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma | Oncology Reports | 2013 | 147 |
43 | Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study. | Oncology Reports | 2000 | 146 |
44 | Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1 | Oncology Reports | 2006 | 146 |
45 | microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2 | Oncology Reports | 2010 | 145 |
46 | Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity | Oncology Reports | 2011 | 145 |
47 | Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. | Oncology Reports | 1999 | 144 |
48 | miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect | Oncology Reports | 2012 | 144 |
49 | microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers | Oncology Reports | 2013 | 144 |
50 | Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: A critical review of non-selective COX-2 blockade (Review) | Oncology Reports | 2005 | 139 |